83 related articles for article (PubMed ID: 17005403)
1. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation.
Périé S; Mamchaoui K; Mouly V; Blot S; Bouazza B; Thornell LE; St Guily JL; Butler-Browne G
Neuromuscul Disord; 2006 Nov; 16(11):770-81. PubMed ID: 17005403
[TBL] [Abstract][Full Text] [Related]
2. PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy.
Shademan M; Mei H; van Engelen B; Ariyurek Y; Kloet S; Raz V
HGG Adv; 2024 Apr; 5(2):100269. PubMed ID: 38213032
[TBL] [Abstract][Full Text] [Related]
3. Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.
Barro M; Carnac G; Flavier S; Mercier J; Vassetzky Y; Laoudj-Chenivesse D
J Cell Mol Med; 2010 Jan; 14(1-2):275-89. PubMed ID: 18505476
[TBL] [Abstract][Full Text] [Related]
4. Oculopharyngeal muscular dystrophy mutations link the RNA-binding protein HNRNPQ to autophagosome biogenesis.
Ishtayeh H; Galves M; Barnatan TT; Berdichevsky Y; Amer-Sarsour F; Pasmanik-Chor M; Braverman I; Blumen SC; Ashkenazi A
Aging Cell; 2023 Oct; 22(10):e13949. PubMed ID: 37559347
[TBL] [Abstract][Full Text] [Related]
5. LMNA-related muscular dystrophy involving myoblast proliferation and apoptosis through the FOXO1/GADD45A pathway.
Wu Y; Zhu X; Jiang W; Li J; Li H; Zhang K; Yang Y; Qu S; Guan X; Bai Y; Guo H; Dai L
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166943. PubMed ID: 37951507
[TBL] [Abstract][Full Text] [Related]
6. Our journey with François Gros.
Butler-Browne G; Mouly V
C R Biol; 2024 Mar; 346(S2):59-63. PubMed ID: 38113101
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer into canine myoblasts.
Braun S; Thioudellet C; Perraud F; Escriou C; Claudepierre MC; Homann H; Lusky M; Mehtali M; Bischoff R; Pavirani A
Cytotechnology; 1999 Jul; 30(1-3):181-9. PubMed ID: 19003368
[TBL] [Abstract][Full Text] [Related]
8. A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.
Anvar SY; Raz Y; Verway N; van der Sluijs B; Venema A; Goeman JJ; Vissing J; van der Maarel SM; 't Hoen PA; van Engelen BG; Raz V
Aging (Albany NY); 2013 Jun; 5(6):412-26. PubMed ID: 23793615
[TBL] [Abstract][Full Text] [Related]
9. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites.
Jenal M; Elkon R; Loayza-Puch F; van Haaften G; Kühn U; Menzies FM; Oude Vrielink JA; Bos AJ; Drost J; Rooijers K; Rubinsztein DC; Agami R
Cell; 2012 Apr; 149(3):538-53. PubMed ID: 22502866
[TBL] [Abstract][Full Text] [Related]
10. Production of Duchenne muscular dystrophy cellular model using CRISPR-Cas9 exon deletion strategy.
Alizadeh F; Abraghan YJ; Farrokhi S; Yousefi Y; Mirahmadi Y; Eslahi A; Mojarrad M
Mol Cell Biochem; 2024 May; 479(5):1027-1040. PubMed ID: 37289342
[TBL] [Abstract][Full Text] [Related]
11. Pharyngeal pathology in a mouse model of oculopharyngeal muscular dystrophy is associated with impaired basal autophagy in myoblasts.
Zhang Y; Zeuthen C; Zhu C; Wu F; Mezzell AT; Whitlow TJ; Choo HJ; Vest KE
Front Cell Dev Biol; 2022; 10():986930. PubMed ID: 36313551
[TBL] [Abstract][Full Text] [Related]
12. Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies.
Ganassi M; Muntoni F; Zammit PS
Exp Cell Res; 2022 Feb; 411(1):112906. PubMed ID: 34740639
[TBL] [Abstract][Full Text] [Related]
13. Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle.
Boyer O; Butler-Browne G; Chinoy H; Cossu G; Galli F; Lilleker JB; Magli A; Mouly V; Perlingeiro RCR; Previtali SC; Sampaolesi M; Smeets H; Schoewel-Wolf V; Spuler S; Torrente Y; Van Tienen F;
Front Genet; 2021; 12():702547. PubMed ID: 34408774
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress in Oculopharyngeal Muscular Dystrophy.
Yamashita S
J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33805441
[TBL] [Abstract][Full Text] [Related]
15. Systemic cell therapy for muscular dystrophies : The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy.
Ausems CRM; van Engelen BGM; van Bokhoven H; Wansink DG
Stem Cell Rev Rep; 2021 Jun; 17(3):878-899. PubMed ID: 33349909
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular Specializations of the Human Hypopharyngeal Muscles.
Mohammed MEA; Mu L; Abdelfattah HM
Dysphagia; 2021 Oct; 36(5):769-785. PubMed ID: 33159539
[TBL] [Abstract][Full Text] [Related]
17. Functional skeletal muscle model derived from SOD1-mutant ALS patient iPSCs recapitulates hallmarks of disease progression.
Badu-Mensah A; Guo X; McAleer CW; Rumsey JW; Hickman JJ
Sci Rep; 2020 Aug; 10(1):14302. PubMed ID: 32868812
[TBL] [Abstract][Full Text] [Related]
18. Impaired Regeneration in Dystrophic Muscle-New Target for Therapy.
Yanay N; Rabie M; Nevo Y
Front Mol Neurosci; 2020; 13():69. PubMed ID: 32523512
[TBL] [Abstract][Full Text] [Related]
19. Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy.
Nguyen Q; Yokota T
J Pers Med; 2017 Oct; 7(4):. PubMed ID: 29035327
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
